Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
Identifieur interne : 000588 ( Main/Exploration ); précédent : 000587; suivant : 000589Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
Auteurs : Amer M. Zeidan [États-Unis] ; Prajwal C. Boddu [États-Unis] ; Mrinal M. Patnaik [États-Unis] ; Jan Philipp Bewersdorf [États-Unis] ; Maximilian Stahl [États-Unis] ; Raajit K. Rampal [États-Unis] ; Rory Shallis [États-Unis] ; David P. Steensma [États-Unis] ; Michael R. Savona [États-Unis] ; Mikkael A. Sekeres [États-Unis] ; Gail J. Roboz [États-Unis] ; Daniel J. Deangelo [États-Unis] ; Andre C. Schuh [Canada] ; Eric Padron [États-Unis] ; Joshua F. Zeidner [États-Unis] ; Roland B. Walter [États-Unis] ; Francesco Onida [Italie] ; Amir Fathi [États-Unis] ; Amy Dezern [États-Unis] ; Gabriela Hobbs [États-Unis] ; Eytan M. Stein [États-Unis] ; Paresh Vyas [Royaume-Uni] ; Andrew H. Wei [Australie] ; David T. Bowen [Royaume-Uni] ; Pau Montesinos [Espagne] ; Elizabeth A. Griffiths [États-Unis] ; Amit K. Verma [États-Unis] ; Alla Keyzner [États-Unis] ; Michal Bar-Natan [États-Unis] ; Shyamala C. Navada [États-Unis] ; Marina Kremyanskaya [États-Unis] ; Aaron D. Goldberg [États-Unis] ; Aref Al-Kali [États-Unis] ; Mark L. Heaney [États-Unis] ; Aziz Nazha [États-Unis] ; Huda Salman [États-Unis] ; Selina Luger [États-Unis] ; Keith W. Pratz [États-Unis] ; Heiko Konig [États-Unis] ; Rami Komrokji [États-Unis] ; Michael Deininger [États-Unis] ; Blanca Xicoy Cirici [Espagne] ; Vijaya Raj Bhatt [États-Unis] ; Lewis R. Silverman [États-Unis] ; Harry P. Erba [États-Unis] ; Pierre Fenaux [France] ; Uwe Platzbecker [Allemagne] ; Valeria Santini [Italie] ; Eunice S. Wang [États-Unis] ; Martin S. Tallman [États-Unis] ; Richard M. Stone [États-Unis] ; John Mascarenhas [États-Unis]Source :
- The Lancet. Haematology [ 2352-3026 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Allocation des ressources (MeSH), Betacoronavirus (pathogénicité), Expertise (MeSH), Guides de bonnes pratiques cliniques comme sujet (normes), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (transmission), Infections à coronavirus (virologie), Leucémies (thérapie), Leucémies (virologie), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (transmission), Pneumopathie virale (virologie), Prise en charge de la maladie (MeSH), Prévention des infections (normes), Syndromes myéloprolifératifs (thérapie), Syndromes myéloprolifératifs (virologie).
- MESH :
- normes : Guides de bonnes pratiques cliniques comme sujet, Prévention des infections.
- pathogénicité : Betacoronavirus.
- thérapie : Leucémies, Syndromes myéloprolifératifs.
- virologie : Infections à coronavirus, Leucémies, Pneumopathie virale, Syndromes myéloprolifératifs.
- complications : Adulte, Allocation des ressources, Expertise, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Prise en charge de la maladie.
English descriptors
- KwdEn :
- Adult (MeSH), Betacoronavirus (pathogenicity), Coronavirus Infections (complications), Coronavirus Infections (transmission), Coronavirus Infections (virology), Disease Management (MeSH), Expert Testimony (MeSH), Humans (MeSH), Infection Control (standards), Leukemia (therapy), Leukemia (virology), Myeloproliferative Disorders (therapy), Myeloproliferative Disorders (virology), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (transmission), Pneumonia, Viral (virology), Practice Guidelines as Topic (standards), Resource Allocation (MeSH).
- MESH :
- complications : Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- standards : Infection Control, Practice Guidelines as Topic.
- therapy : Leukemia, Myeloproliferative Disorders.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- virology : Coronavirus Infections, Leukemia, Myeloproliferative Disorders, Pneumonia, Viral.
- Adult, Disease Management, Expert Testimony, Humans, Pandemics, Resource Allocation.
Abstract
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.
DOI: 10.1016/S2352-3026(20)30205-2
PubMed: 32563283
PubMed Central: PMC7302757
Affiliations:
- Allemagne, Australie, Canada, Espagne, France, Italie, Royaume-Uni, États-Unis
- Angleterre, Caroline du Nord, Catalogne, Communauté de Madrid, Connecticut, District de Leipzig, Floride, Indiana, Lombardie, Maryland, Massachusetts, Minnesota, Nebraska, Ohio, Ontario, Oxfordshire, Pennsylvanie, Saxe (Land), Tennessee, Utah, Washington (État), État de New York, Île-de-France
- Barcelone, Leipzig, Madrid, Milan, New York, Oxford, Paris, Toronto
- Université Columbia, Université autonome de Barcelone, Université d'Oxford, Université de Toronto
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.</title><author><name sortKey="Zeidan, Amer M" sort="Zeidan, Amer M" uniqKey="Zeidan A" first="Amer M" last="Zeidan">Amer M. Zeidan</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Boddu, Prajwal C" sort="Boddu, Prajwal C" uniqKey="Boddu P" first="Prajwal C" last="Boddu">Prajwal C. Boddu</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Patnaik, Mrinal M" sort="Patnaik, Mrinal M" uniqKey="Patnaik M" first="Mrinal M" last="Patnaik">Mrinal M. Patnaik</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Mayo Clinic, Rochester, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Bewersdorf, Jan Philipp" sort="Bewersdorf, Jan Philipp" uniqKey="Bewersdorf J" first="Jan Philipp" last="Bewersdorf">Jan Philipp Bewersdorf</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Stahl, Maximilian" sort="Stahl, Maximilian" uniqKey="Stahl M" first="Maximilian" last="Stahl">Maximilian Stahl</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Rampal, Raajit K" sort="Rampal, Raajit K" uniqKey="Rampal R" first="Raajit K" last="Rampal">Raajit K. Rampal</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shallis, Rory" sort="Shallis, Rory" uniqKey="Shallis R" first="Rory" last="Shallis">Rory Shallis</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Steensma, David P" sort="Steensma, David P" uniqKey="Steensma D" first="David P" last="Steensma">David P. Steensma</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Savona, Michael R" sort="Savona, Michael R" uniqKey="Savona M" first="Michael R" last="Savona">Michael R. Savona</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Sekeres, Mikkael A" sort="Sekeres, Mikkael A" uniqKey="Sekeres M" first="Mikkael A" last="Sekeres">Mikkael A. Sekeres</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Roboz, Gail J" sort="Roboz, Gail J" uniqKey="Roboz G" first="Gail J" last="Roboz">Gail J. Roboz</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Deangelo, Daniel J" sort="Deangelo, Daniel J" uniqKey="Deangelo D" first="Daniel J" last="Deangelo">Daniel J. Deangelo</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Schuh, Andre C" sort="Schuh, Andre C" uniqKey="Schuh A" first="Andre C" last="Schuh">Andre C. Schuh</name><affiliation wicri:level="4"><nlm:affiliation>Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Padron, Eric" sort="Padron, Eric" uniqKey="Padron E" first="Eric" last="Padron">Eric Padron</name><affiliation wicri:level="2"><nlm:affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Zeidner, Joshua F" sort="Zeidner, Joshua F" uniqKey="Zeidner J" first="Joshua F" last="Zeidner">Joshua F. Zeidner</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Walter, Roland B" sort="Walter, Roland B" uniqKey="Walter R" first="Roland B" last="Walter">Roland B. Walter</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA</wicri:regionArea><placeName><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Onida, Francesco" sort="Onida, Francesco" uniqKey="Onida F" first="Francesco" last="Onida">Francesco Onida</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Fathi, Amir" sort="Fathi, Amir" uniqKey="Fathi A" first="Amir" last="Fathi">Amir Fathi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Dezern, Amy" sort="Dezern, Amy" uniqKey="Dezern A" first="Amy" last="Dezern">Amy Dezern</name><affiliation wicri:level="2"><nlm:affiliation>Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Hobbs, Gabriela" sort="Hobbs, Gabriela" uniqKey="Hobbs G" first="Gabriela" last="Hobbs">Gabriela Hobbs</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Stein, Eytan M" sort="Stein, Eytan M" uniqKey="Stein E" first="Eytan M" last="Stein">Eytan M. Stein</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Vyas, Paresh" sort="Vyas, Paresh" uniqKey="Vyas P" first="Paresh" last="Vyas">Paresh Vyas</name><affiliation wicri:level="4"><nlm:affiliation>MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Wei, Andrew H" sort="Wei, Andrew H" uniqKey="Wei A" first="Andrew H" last="Wei">Andrew H. Wei</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Bowen, David T" sort="Bowen, David T" uniqKey="Bowen D" first="David T" last="Bowen">David T. Bowen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds</wicri:regionArea><wicri:noRegion>Leeds</wicri:noRegion></affiliation></author><author><name sortKey="Montesinos, Pau" sort="Montesinos, Pau" uniqKey="Montesinos P" first="Pau" last="Montesinos">Pau Montesinos</name><affiliation wicri:level="3"><nlm:affiliation>Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Griffiths, Elizabeth A" sort="Griffiths, Elizabeth A" uniqKey="Griffiths E" first="Elizabeth A" last="Griffiths">Elizabeth A. Griffiths</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Verma, Amit K" sort="Verma, Amit K" uniqKey="Verma A" first="Amit K" last="Verma">Amit K. Verma</name><affiliation wicri:level="2"><nlm:affiliation>Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Keyzner, Alla" sort="Keyzner, Alla" uniqKey="Keyzner A" first="Alla" last="Keyzner">Alla Keyzner</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Bar Natan, Michal" sort="Bar Natan, Michal" uniqKey="Bar Natan M" first="Michal" last="Bar-Natan">Michal Bar-Natan</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Navada, Shyamala C" sort="Navada, Shyamala C" uniqKey="Navada S" first="Shyamala C" last="Navada">Shyamala C. Navada</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Kremyanskaya, Marina" sort="Kremyanskaya, Marina" uniqKey="Kremyanskaya M" first="Marina" last="Kremyanskaya">Marina Kremyanskaya</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Goldberg, Aaron D" sort="Goldberg, Aaron D" uniqKey="Goldberg A" first="Aaron D" last="Goldberg">Aaron D. Goldberg</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Al Kali, Aref" sort="Al Kali, Aref" uniqKey="Al Kali A" first="Aref" last="Al-Kali">Aref Al-Kali</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Mayo Clinic, Rochester, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Heaney, Mark L" sort="Heaney, Mark L" uniqKey="Heaney M" first="Mark L" last="Heaney">Mark L. Heaney</name><affiliation wicri:level="4"><nlm:affiliation>Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region><settlement type="city">New York</settlement></placeName><orgName type="university">Université Columbia</orgName></affiliation></author><author><name sortKey="Nazha, Aziz" sort="Nazha, Aziz" uniqKey="Nazha A" first="Aziz" last="Nazha">Aziz Nazha</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Salman, Huda" sort="Salman, Huda" uniqKey="Salman H" first="Huda" last="Salman">Huda Salman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Luger, Selina" sort="Luger, Selina" uniqKey="Luger S" first="Selina" last="Luger">Selina Luger</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Pratz, Keith W" sort="Pratz, Keith W" uniqKey="Pratz K" first="Keith W" last="Pratz">Keith W. Pratz</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Konig, Heiko" sort="Konig, Heiko" uniqKey="Konig H" first="Heiko" last="Konig">Heiko Konig</name><affiliation wicri:level="2"><nlm:affiliation>Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Komrokji, Rami" sort="Komrokji, Rami" uniqKey="Komrokji R" first="Rami" last="Komrokji">Rami Komrokji</name><affiliation wicri:level="2"><nlm:affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Deininger, Michael" sort="Deininger, Michael" uniqKey="Deininger M" first="Michael" last="Deininger">Michael Deininger</name><affiliation wicri:level="2"><nlm:affiliation>Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT</wicri:regionArea><placeName><region type="state">Utah</region></placeName></affiliation></author><author><name sortKey="Cirici, Blanca Xicoy" sort="Cirici, Blanca Xicoy" uniqKey="Cirici B" first="Blanca Xicoy" last="Cirici">Blanca Xicoy Cirici</name><affiliation wicri:level="4"><nlm:affiliation>Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université autonome de Barcelone</orgName></affiliation></author><author><name sortKey="Bhatt, Vijaya Raj" sort="Bhatt, Vijaya Raj" uniqKey="Bhatt V" first="Vijaya Raj" last="Bhatt">Vijaya Raj Bhatt</name><affiliation wicri:level="2"><nlm:affiliation>Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE</wicri:regionArea><placeName><region type="state">Nebraska</region></placeName></affiliation></author><author><name sortKey="Silverman, Lewis R" sort="Silverman, Lewis R" uniqKey="Silverman L" first="Lewis R" last="Silverman">Lewis R. Silverman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Erba, Harry P" sort="Erba, Harry P" uniqKey="Erba H" first="Harry P" last="Erba">Harry P. Erba</name><affiliation wicri:level="2"><nlm:affiliation>Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Platzbecker, Uwe" sort="Platzbecker, Uwe" uniqKey="Platzbecker U" first="Uwe" last="Platzbecker">Uwe Platzbecker</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Leipzig</region><settlement type="city">Leipzig</settlement></placeName></affiliation></author><author><name sortKey="Santini, Valeria" sort="Santini, Valeria" uniqKey="Santini V" first="Valeria" last="Santini">Valeria Santini</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Florence Medical School, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Medicine, University of Florence Medical School, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Eunice S" sort="Wang, Eunice S" uniqKey="Wang E" first="Eunice S" last="Wang">Eunice S. Wang</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Tallman, Martin S" sort="Tallman, Martin S" uniqKey="Tallman M" first="Martin S" last="Tallman">Martin S. Tallman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Stone, Richard M" sort="Stone, Richard M" uniqKey="Stone R" first="Richard M" last="Stone">Richard M. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Mascarenhas, John" sort="Mascarenhas, John" uniqKey="Mascarenhas J" first="John" last="Mascarenhas">John Mascarenhas</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32563283</idno><idno type="pmid">32563283</idno><idno type="doi">10.1016/S2352-3026(20)30205-2</idno><idno type="pmc">PMC7302757</idno><idno type="wicri:Area/Main/Corpus">000C86</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C86</idno><idno type="wicri:Area/Main/Curation">000C86</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C86</idno><idno type="wicri:Area/Main/Exploration">000C86</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.</title><author><name sortKey="Zeidan, Amer M" sort="Zeidan, Amer M" uniqKey="Zeidan A" first="Amer M" last="Zeidan">Amer M. Zeidan</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Boddu, Prajwal C" sort="Boddu, Prajwal C" uniqKey="Boddu P" first="Prajwal C" last="Boddu">Prajwal C. Boddu</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Patnaik, Mrinal M" sort="Patnaik, Mrinal M" uniqKey="Patnaik M" first="Mrinal M" last="Patnaik">Mrinal M. Patnaik</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Mayo Clinic, Rochester, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Bewersdorf, Jan Philipp" sort="Bewersdorf, Jan Philipp" uniqKey="Bewersdorf J" first="Jan Philipp" last="Bewersdorf">Jan Philipp Bewersdorf</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Stahl, Maximilian" sort="Stahl, Maximilian" uniqKey="Stahl M" first="Maximilian" last="Stahl">Maximilian Stahl</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Rampal, Raajit K" sort="Rampal, Raajit K" uniqKey="Rampal R" first="Raajit K" last="Rampal">Raajit K. Rampal</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shallis, Rory" sort="Shallis, Rory" uniqKey="Shallis R" first="Rory" last="Shallis">Rory Shallis</name><affiliation wicri:level="2"><nlm:affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Steensma, David P" sort="Steensma, David P" uniqKey="Steensma D" first="David P" last="Steensma">David P. Steensma</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Savona, Michael R" sort="Savona, Michael R" uniqKey="Savona M" first="Michael R" last="Savona">Michael R. Savona</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN</wicri:regionArea><placeName><region type="state">Tennessee</region></placeName></affiliation></author><author><name sortKey="Sekeres, Mikkael A" sort="Sekeres, Mikkael A" uniqKey="Sekeres M" first="Mikkael A" last="Sekeres">Mikkael A. Sekeres</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Roboz, Gail J" sort="Roboz, Gail J" uniqKey="Roboz G" first="Gail J" last="Roboz">Gail J. Roboz</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Deangelo, Daniel J" sort="Deangelo, Daniel J" uniqKey="Deangelo D" first="Daniel J" last="Deangelo">Daniel J. Deangelo</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Schuh, Andre C" sort="Schuh, Andre C" uniqKey="Schuh A" first="Andre C" last="Schuh">Andre C. Schuh</name><affiliation wicri:level="4"><nlm:affiliation>Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Padron, Eric" sort="Padron, Eric" uniqKey="Padron E" first="Eric" last="Padron">Eric Padron</name><affiliation wicri:level="2"><nlm:affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Zeidner, Joshua F" sort="Zeidner, Joshua F" uniqKey="Zeidner J" first="Joshua F" last="Zeidner">Joshua F. Zeidner</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Walter, Roland B" sort="Walter, Roland B" uniqKey="Walter R" first="Roland B" last="Walter">Roland B. Walter</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA</wicri:regionArea><placeName><region type="state">Washington (État)</region></placeName></affiliation></author><author><name sortKey="Onida, Francesco" sort="Onida, Francesco" uniqKey="Onida F" first="Francesco" last="Onida">Francesco Onida</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Fathi, Amir" sort="Fathi, Amir" uniqKey="Fathi A" first="Amir" last="Fathi">Amir Fathi</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Dezern, Amy" sort="Dezern, Amy" uniqKey="Dezern A" first="Amy" last="Dezern">Amy Dezern</name><affiliation wicri:level="2"><nlm:affiliation>Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Hobbs, Gabriela" sort="Hobbs, Gabriela" uniqKey="Hobbs G" first="Gabriela" last="Hobbs">Gabriela Hobbs</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Stein, Eytan M" sort="Stein, Eytan M" uniqKey="Stein E" first="Eytan M" last="Stein">Eytan M. Stein</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Vyas, Paresh" sort="Vyas, Paresh" uniqKey="Vyas P" first="Paresh" last="Vyas">Paresh Vyas</name><affiliation wicri:level="4"><nlm:affiliation>MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford</wicri:regionArea><placeName><settlement type="city">Oxford</settlement><region type="country">Angleterre</region><region type="comté" nuts="2">Oxfordshire</region></placeName><orgName type="university">Université d'Oxford</orgName></affiliation></author><author><name sortKey="Wei, Andrew H" sort="Wei, Andrew H" uniqKey="Wei A" first="Andrew H" last="Wei">Andrew H. Wei</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC</wicri:regionArea><wicri:noRegion>VIC</wicri:noRegion></affiliation></author><author><name sortKey="Bowen, David T" sort="Bowen, David T" uniqKey="Bowen D" first="David T" last="Bowen">David T. Bowen</name><affiliation wicri:level="1"><nlm:affiliation>Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds</wicri:regionArea><wicri:noRegion>Leeds</wicri:noRegion></affiliation></author><author><name sortKey="Montesinos, Pau" sort="Montesinos, Pau" uniqKey="Montesinos P" first="Pau" last="Montesinos">Pau Montesinos</name><affiliation wicri:level="3"><nlm:affiliation>Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Griffiths, Elizabeth A" sort="Griffiths, Elizabeth A" uniqKey="Griffiths E" first="Elizabeth A" last="Griffiths">Elizabeth A. Griffiths</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Verma, Amit K" sort="Verma, Amit K" uniqKey="Verma A" first="Amit K" last="Verma">Amit K. Verma</name><affiliation wicri:level="2"><nlm:affiliation>Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Keyzner, Alla" sort="Keyzner, Alla" uniqKey="Keyzner A" first="Alla" last="Keyzner">Alla Keyzner</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Bar Natan, Michal" sort="Bar Natan, Michal" uniqKey="Bar Natan M" first="Michal" last="Bar-Natan">Michal Bar-Natan</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Navada, Shyamala C" sort="Navada, Shyamala C" uniqKey="Navada S" first="Shyamala C" last="Navada">Shyamala C. Navada</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Kremyanskaya, Marina" sort="Kremyanskaya, Marina" uniqKey="Kremyanskaya M" first="Marina" last="Kremyanskaya">Marina Kremyanskaya</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Goldberg, Aaron D" sort="Goldberg, Aaron D" uniqKey="Goldberg A" first="Aaron D" last="Goldberg">Aaron D. Goldberg</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Al Kali, Aref" sort="Al Kali, Aref" uniqKey="Al Kali A" first="Aref" last="Al-Kali">Aref Al-Kali</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Mayo Clinic, Rochester, MN</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Heaney, Mark L" sort="Heaney, Mark L" uniqKey="Heaney M" first="Mark L" last="Heaney">Mark L. Heaney</name><affiliation wicri:level="4"><nlm:affiliation>Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region><settlement type="city">New York</settlement></placeName><orgName type="university">Université Columbia</orgName></affiliation></author><author><name sortKey="Nazha, Aziz" sort="Nazha, Aziz" uniqKey="Nazha A" first="Aziz" last="Nazha">Aziz Nazha</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH</wicri:regionArea><placeName><region type="state">Ohio</region></placeName></affiliation></author><author><name sortKey="Salman, Huda" sort="Salman, Huda" uniqKey="Salman H" first="Huda" last="Salman">Huda Salman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Luger, Selina" sort="Luger, Selina" uniqKey="Luger S" first="Selina" last="Luger">Selina Luger</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Pratz, Keith W" sort="Pratz, Keith W" uniqKey="Pratz K" first="Keith W" last="Pratz">Keith W. Pratz</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Konig, Heiko" sort="Konig, Heiko" uniqKey="Konig H" first="Heiko" last="Konig">Heiko Konig</name><affiliation wicri:level="2"><nlm:affiliation>Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN</wicri:regionArea><placeName><region type="state">Indiana</region></placeName></affiliation></author><author><name sortKey="Komrokji, Rami" sort="Komrokji, Rami" uniqKey="Komrokji R" first="Rami" last="Komrokji">Rami Komrokji</name><affiliation wicri:level="2"><nlm:affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Deininger, Michael" sort="Deininger, Michael" uniqKey="Deininger M" first="Michael" last="Deininger">Michael Deininger</name><affiliation wicri:level="2"><nlm:affiliation>Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT</wicri:regionArea><placeName><region type="state">Utah</region></placeName></affiliation></author><author><name sortKey="Cirici, Blanca Xicoy" sort="Cirici, Blanca Xicoy" uniqKey="Cirici B" first="Blanca Xicoy" last="Cirici">Blanca Xicoy Cirici</name><affiliation wicri:level="4"><nlm:affiliation>Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName><orgName type="university">Université autonome de Barcelone</orgName></affiliation></author><author><name sortKey="Bhatt, Vijaya Raj" sort="Bhatt, Vijaya Raj" uniqKey="Bhatt V" first="Vijaya Raj" last="Bhatt">Vijaya Raj Bhatt</name><affiliation wicri:level="2"><nlm:affiliation>Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE</wicri:regionArea><placeName><region type="state">Nebraska</region></placeName></affiliation></author><author><name sortKey="Silverman, Lewis R" sort="Silverman, Lewis R" uniqKey="Silverman L" first="Lewis R" last="Silverman">Lewis R. Silverman</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Erba, Harry P" sort="Erba, Harry P" uniqKey="Erba H" first="Harry P" last="Erba">Harry P. Erba</name><affiliation wicri:level="2"><nlm:affiliation>Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region></placeName></affiliation></author><author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name><affiliation wicri:level="3"><nlm:affiliation>Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Platzbecker, Uwe" sort="Platzbecker, Uwe" uniqKey="Platzbecker U" first="Uwe" last="Platzbecker">Uwe Platzbecker</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig</wicri:regionArea><placeName><region type="land" nuts="1">Saxe (Land)</region><region type="district" nuts="2">District de Leipzig</region><settlement type="city">Leipzig</settlement></placeName></affiliation></author><author><name sortKey="Santini, Valeria" sort="Santini, Valeria" uniqKey="Santini V" first="Valeria" last="Santini">Valeria Santini</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, University of Florence Medical School, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Medicine, University of Florence Medical School, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Wang, Eunice S" sort="Wang, Eunice S" uniqKey="Wang E" first="Eunice S" last="Wang">Eunice S. Wang</name><affiliation wicri:level="2"><nlm:affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Tallman, Martin S" sort="Tallman, Martin S" uniqKey="Tallman M" first="Martin S" last="Tallman">Martin S. Tallman</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Stone, Richard M" sort="Stone, Richard M" uniqKey="Stone R" first="Richard M" last="Stone">Richard M. Stone</name><affiliation wicri:level="2"><nlm:affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Mascarenhas, John" sort="Mascarenhas, John" uniqKey="Mascarenhas J" first="John" last="Mascarenhas">John Mascarenhas</name><affiliation wicri:level="2"><nlm:affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author></analytic><series><title level="j">The Lancet. Haematology</title><idno type="eISSN">2352-3026</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Betacoronavirus (pathogenicity)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (transmission)</term><term>Coronavirus Infections (virology)</term><term>Disease Management (MeSH)</term><term>Expert Testimony (MeSH)</term><term>Humans (MeSH)</term><term>Infection Control (standards)</term><term>Leukemia (therapy)</term><term>Leukemia (virology)</term><term>Myeloproliferative Disorders (therapy)</term><term>Myeloproliferative Disorders (virology)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (transmission)</term><term>Pneumonia, Viral (virology)</term><term>Practice Guidelines as Topic (standards)</term><term>Resource Allocation (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Allocation des ressources (MeSH)</term><term>Betacoronavirus (pathogénicité)</term><term>Expertise (MeSH)</term><term>Guides de bonnes pratiques cliniques comme sujet (normes)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (virologie)</term><term>Leucémies (thérapie)</term><term>Leucémies (virologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (transmission)</term><term>Pneumopathie virale (virologie)</term><term>Prise en charge de la maladie (MeSH)</term><term>Prévention des infections (normes)</term><term>Syndromes myéloprolifératifs (thérapie)</term><term>Syndromes myéloprolifératifs (virologie)</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Prévention des infections</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Infection Control</term><term>Practice Guidelines as Topic</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Leukemia</term><term>Myeloproliferative Disorders</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Leucémies</term><term>Syndromes myéloprolifératifs</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Leucémies</term><term>Pneumopathie virale</term><term>Syndromes myéloprolifératifs</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term><term>Leukemia</term><term>Myeloproliferative Disorders</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Disease Management</term><term>Expert Testimony</term><term>Humans</term><term>Pandemics</term><term>Resource Allocation</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="fr"><term>Adulte</term><term>Allocation des ressources</term><term>Expertise</term><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Prise en charge de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32563283</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3026</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Lancet. Haematology</Title><ISOAbbreviation>Lancet Haematol</ISOAbbreviation></Journal><ArticleTitle>Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.</ArticleTitle><Pagination><MedlinePgn>e601-e612</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S2352-3026(20)30205-2</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2352-3026(20)30205-2</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 is a global public health crisis. Multiple observations indicate poorer post-infection outcomes for patients with cancer than for the general population. Herein, we highlight the challenges in caring for patients with acute leukaemias and myeloid neoplasms amid the COVID-19 pandemic. We summarise key changes related to service allocation, clinical and supportive care, clinical trial participation, and ethical considerations regarding the use of lifesaving measures for these patients. We recognise that these recommendations might be more applicable to high-income countries and might not be generalisable because of regional differences in health-care infrastructure, individual circumstances, and a complex and highly fluid health-care environment. Despite these limitations, we aim to provide a general framework for the care of patients with acute leukaemias and myeloid neoplasms during the COVID-19 pandemic on the basis of recommendations from international experts.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeidan</LastName><ForeName>Amer M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boddu</LastName><ForeName>Prajwal C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patnaik</LastName><ForeName>Mrinal M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bewersdorf</LastName><ForeName>Jan Philipp</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stahl</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rampal</LastName><ForeName>Raajit K</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shallis</LastName><ForeName>Rory</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Hematology, Yale School of Medicine, Yale University, New Haven, CT, USA; Yale Comprehensive Cancer Center, Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steensma</LastName><ForeName>David P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savona</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Hematology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekeres</LastName><ForeName>Mikkael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Leukemia Program, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roboz</LastName><ForeName>Gail J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeAngelo</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuh</LastName><ForeName>Andre C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padron</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeidner</LastName><ForeName>Joshua F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Lineberger Comprehensive Care Center, University of North Carolina, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Roland B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Division of Hematology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onida</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Hematology, IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fathi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeZern</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hobbs</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Hematology, Centre for Leukemia, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Eytan M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vyas</LastName><ForeName>Paresh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC Molecular Haematology Unit, BRC Oxford Department of Haematology, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Andrew H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Clinical Haematology, Alfred Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>David T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Haematology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montesinos</LastName><ForeName>Pau</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Haematology, Hospital Universitario y Politecnico La Fe, Valencia, Spain; CIBERONC, Instituto Carlos III, University of Valencia, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffiths</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Amit K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keyzner</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar-Natan</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navada</LastName><ForeName>Shyamala C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kremyanskaya</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Aaron D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Kali</LastName><ForeName>Aref</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heaney</LastName><ForeName>Mark L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Hematology, Herbert Irving Comprehensive Care Centre, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazha</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology, Cleveland Clinic-Taussig Cancer Institute, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salman</LastName><ForeName>Huda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Stony Brook University Cancer Center, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luger</LastName><ForeName>Selina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratz</LastName><ForeName>Keith W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Hematology and Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konig</LastName><ForeName>Heiko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, Indiana University, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komrokji</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deininger</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Huntsman Cancer Institute, Department of Medicine, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirici</LastName><ForeName>Blanca Xicoy</ForeName><Initials>BX</Initials><AffiliationInfo><Affiliation>Clinical Haematology Department, Josep Carreras Leukaemia Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Vijaya Raj</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Fred and Pamela Buffett Cancer Center, Department of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverman</LastName><ForeName>Lewis R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erba</LastName><ForeName>Harry P</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Duke Cancer Institute, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapies, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenaux</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hôpital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; Department of Haematology, Paris University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Platzbecker</LastName><ForeName>Uwe</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Translational Hematology, Leipzig University Hospital, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santini</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Florence Medical School, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eunice S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallman</LastName><ForeName>Martin S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Hematology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Hematology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mascarenhas</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 CA087723</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA016359</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Haematol</MedlineTA><NlmUniqueID>101643584</NlmUniqueID><ISSNLinking>2352-3026</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005104" MajorTopicYN="N">Expert Testimony</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007938" MajorTopicYN="N">Leukemia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009196" MajorTopicYN="N">Myeloproliferative Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040841" MajorTopicYN="N">Resource Allocation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>05</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32563283</ArticleId><ArticleId IdType="pii">S2352-3026(20)30205-2</ArticleId><ArticleId IdType="doi">10.1016/S2352-3026(20)30205-2</ArticleId><ArticleId IdType="pmc">PMC7302757</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Canada</li><li>Espagne</li><li>France</li><li>Italie</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Caroline du Nord</li><li>Catalogne</li><li>Communauté de Madrid</li><li>Connecticut</li><li>District de Leipzig</li><li>Floride</li><li>Indiana</li><li>Lombardie</li><li>Maryland</li><li>Massachusetts</li><li>Minnesota</li><li>Nebraska</li><li>Ohio</li><li>Ontario</li><li>Oxfordshire</li><li>Pennsylvanie</li><li>Saxe (Land)</li><li>Tennessee</li><li>Utah</li><li>Washington (État)</li><li>État de New York</li><li>Île-de-France</li></region><settlement><li>Barcelone</li><li>Leipzig</li><li>Madrid</li><li>Milan</li><li>New York</li><li>Oxford</li><li>Paris</li><li>Toronto</li></settlement><orgName><li>Université Columbia</li><li>Université autonome de Barcelone</li><li>Université d'Oxford</li><li>Université de Toronto</li></orgName></list><tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Zeidan, Amer M" sort="Zeidan, Amer M" uniqKey="Zeidan A" first="Amer M" last="Zeidan">Amer M. Zeidan</name></region><name sortKey="Al Kali, Aref" sort="Al Kali, Aref" uniqKey="Al Kali A" first="Aref" last="Al-Kali">Aref Al-Kali</name><name sortKey="Bar Natan, Michal" sort="Bar Natan, Michal" uniqKey="Bar Natan M" first="Michal" last="Bar-Natan">Michal Bar-Natan</name><name sortKey="Bewersdorf, Jan Philipp" sort="Bewersdorf, Jan Philipp" uniqKey="Bewersdorf J" first="Jan Philipp" last="Bewersdorf">Jan Philipp Bewersdorf</name><name sortKey="Bhatt, Vijaya Raj" sort="Bhatt, Vijaya Raj" uniqKey="Bhatt V" first="Vijaya Raj" last="Bhatt">Vijaya Raj Bhatt</name><name sortKey="Boddu, Prajwal C" sort="Boddu, Prajwal C" uniqKey="Boddu P" first="Prajwal C" last="Boddu">Prajwal C. Boddu</name><name sortKey="Deangelo, Daniel J" sort="Deangelo, Daniel J" uniqKey="Deangelo D" first="Daniel J" last="Deangelo">Daniel J. Deangelo</name><name sortKey="Deininger, Michael" sort="Deininger, Michael" uniqKey="Deininger M" first="Michael" last="Deininger">Michael Deininger</name><name sortKey="Dezern, Amy" sort="Dezern, Amy" uniqKey="Dezern A" first="Amy" last="Dezern">Amy Dezern</name><name sortKey="Erba, Harry P" sort="Erba, Harry P" uniqKey="Erba H" first="Harry P" last="Erba">Harry P. Erba</name><name sortKey="Fathi, Amir" sort="Fathi, Amir" uniqKey="Fathi A" first="Amir" last="Fathi">Amir Fathi</name><name sortKey="Goldberg, Aaron D" sort="Goldberg, Aaron D" uniqKey="Goldberg A" first="Aaron D" last="Goldberg">Aaron D. Goldberg</name><name sortKey="Griffiths, Elizabeth A" sort="Griffiths, Elizabeth A" uniqKey="Griffiths E" first="Elizabeth A" last="Griffiths">Elizabeth A. Griffiths</name><name sortKey="Heaney, Mark L" sort="Heaney, Mark L" uniqKey="Heaney M" first="Mark L" last="Heaney">Mark L. Heaney</name><name sortKey="Hobbs, Gabriela" sort="Hobbs, Gabriela" uniqKey="Hobbs G" first="Gabriela" last="Hobbs">Gabriela Hobbs</name><name sortKey="Keyzner, Alla" sort="Keyzner, Alla" uniqKey="Keyzner A" first="Alla" last="Keyzner">Alla Keyzner</name><name sortKey="Komrokji, Rami" sort="Komrokji, Rami" uniqKey="Komrokji R" first="Rami" last="Komrokji">Rami Komrokji</name><name sortKey="Konig, Heiko" sort="Konig, Heiko" uniqKey="Konig H" first="Heiko" last="Konig">Heiko Konig</name><name sortKey="Kremyanskaya, Marina" sort="Kremyanskaya, Marina" uniqKey="Kremyanskaya M" first="Marina" last="Kremyanskaya">Marina Kremyanskaya</name><name sortKey="Luger, Selina" sort="Luger, Selina" uniqKey="Luger S" first="Selina" last="Luger">Selina Luger</name><name sortKey="Mascarenhas, John" sort="Mascarenhas, John" uniqKey="Mascarenhas J" first="John" last="Mascarenhas">John Mascarenhas</name><name sortKey="Navada, Shyamala C" sort="Navada, Shyamala C" uniqKey="Navada S" first="Shyamala C" last="Navada">Shyamala C. Navada</name><name sortKey="Nazha, Aziz" sort="Nazha, Aziz" uniqKey="Nazha A" first="Aziz" last="Nazha">Aziz Nazha</name><name sortKey="Padron, Eric" sort="Padron, Eric" uniqKey="Padron E" first="Eric" last="Padron">Eric Padron</name><name sortKey="Patnaik, Mrinal M" sort="Patnaik, Mrinal M" uniqKey="Patnaik M" first="Mrinal M" last="Patnaik">Mrinal M. Patnaik</name><name sortKey="Pratz, Keith W" sort="Pratz, Keith W" uniqKey="Pratz K" first="Keith W" last="Pratz">Keith W. Pratz</name><name sortKey="Rampal, Raajit K" sort="Rampal, Raajit K" uniqKey="Rampal R" first="Raajit K" last="Rampal">Raajit K. Rampal</name><name sortKey="Roboz, Gail J" sort="Roboz, Gail J" uniqKey="Roboz G" first="Gail J" last="Roboz">Gail J. Roboz</name><name sortKey="Salman, Huda" sort="Salman, Huda" uniqKey="Salman H" first="Huda" last="Salman">Huda Salman</name><name sortKey="Savona, Michael R" sort="Savona, Michael R" uniqKey="Savona M" first="Michael R" last="Savona">Michael R. Savona</name><name sortKey="Sekeres, Mikkael A" sort="Sekeres, Mikkael A" uniqKey="Sekeres M" first="Mikkael A" last="Sekeres">Mikkael A. Sekeres</name><name sortKey="Shallis, Rory" sort="Shallis, Rory" uniqKey="Shallis R" first="Rory" last="Shallis">Rory Shallis</name><name sortKey="Silverman, Lewis R" sort="Silverman, Lewis R" uniqKey="Silverman L" first="Lewis R" last="Silverman">Lewis R. Silverman</name><name sortKey="Stahl, Maximilian" sort="Stahl, Maximilian" uniqKey="Stahl M" first="Maximilian" last="Stahl">Maximilian Stahl</name><name sortKey="Steensma, David P" sort="Steensma, David P" uniqKey="Steensma D" first="David P" last="Steensma">David P. Steensma</name><name sortKey="Stein, Eytan M" sort="Stein, Eytan M" uniqKey="Stein E" first="Eytan M" last="Stein">Eytan M. Stein</name><name sortKey="Stone, Richard M" sort="Stone, Richard M" uniqKey="Stone R" first="Richard M" last="Stone">Richard M. Stone</name><name sortKey="Tallman, Martin S" sort="Tallman, Martin S" uniqKey="Tallman M" first="Martin S" last="Tallman">Martin S. Tallman</name><name sortKey="Verma, Amit K" sort="Verma, Amit K" uniqKey="Verma A" first="Amit K" last="Verma">Amit K. Verma</name><name sortKey="Walter, Roland B" sort="Walter, Roland B" uniqKey="Walter R" first="Roland B" last="Walter">Roland B. Walter</name><name sortKey="Wang, Eunice S" sort="Wang, Eunice S" uniqKey="Wang E" first="Eunice S" last="Wang">Eunice S. Wang</name><name sortKey="Zeidner, Joshua F" sort="Zeidner, Joshua F" uniqKey="Zeidner J" first="Joshua F" last="Zeidner">Joshua F. Zeidner</name></country><country name="Canada"><region name="Ontario"><name sortKey="Schuh, Andre C" sort="Schuh, Andre C" uniqKey="Schuh A" first="Andre C" last="Schuh">Andre C. Schuh</name></region></country><country name="Italie"><region name="Lombardie"><name sortKey="Onida, Francesco" sort="Onida, Francesco" uniqKey="Onida F" first="Francesco" last="Onida">Francesco Onida</name></region><name sortKey="Santini, Valeria" sort="Santini, Valeria" uniqKey="Santini V" first="Valeria" last="Santini">Valeria Santini</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Vyas, Paresh" sort="Vyas, Paresh" uniqKey="Vyas P" first="Paresh" last="Vyas">Paresh Vyas</name></region><name sortKey="Bowen, David T" sort="Bowen, David T" uniqKey="Bowen D" first="David T" last="Bowen">David T. Bowen</name></country><country name="Australie"><noRegion><name sortKey="Wei, Andrew H" sort="Wei, Andrew H" uniqKey="Wei A" first="Andrew H" last="Wei">Andrew H. Wei</name></noRegion></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Montesinos, Pau" sort="Montesinos, Pau" uniqKey="Montesinos P" first="Pau" last="Montesinos">Pau Montesinos</name></region><name sortKey="Cirici, Blanca Xicoy" sort="Cirici, Blanca Xicoy" uniqKey="Cirici B" first="Blanca Xicoy" last="Cirici">Blanca Xicoy Cirici</name></country><country name="France"><region name="Île-de-France"><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name></region></country><country name="Allemagne"><region name="Saxe (Land)"><name sortKey="Platzbecker, Uwe" sort="Platzbecker, Uwe" uniqKey="Platzbecker U" first="Uwe" last="Platzbecker">Uwe Platzbecker</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000588 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000588 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32563283
|texte= Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32563283" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |